Lisa A Gustafson, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 19 years
- Graduated 2007
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lisa A Gustafson’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C18044 · Deceased
Licence status: Deceased · since 1956 · Indiana University School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$30,207
Medicare paid this office $30,207 for 72 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 47 | $18,951 | $141 |
| Return visit (30+ min) | 21 | $4,031 | $103 |
| New patient visit (60+ min) | 22 | $3,597 | $163 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 21 | $881 | $25 |
Who their Medicare patients are
72 Original Medicare patients in 2024. Average age 75 · Women 63% · Also on Medicaid 39% · Health risk score 3.42. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Cancer 49% · Diabetes 39% · Chronic kidney disease 35% · Coronary heart disease 29% · Heart failure 29% · Depression 28% · Atrial fibrillation 25% · COPD 17% · Stroke 15%.
The office billed $201,663, Medicare allowed $39,503 and paid $30,207; for 262 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 72 | 262 | 75 | 3.42 | $201,663 | $30,207 |
| 2023 | 77 | 294 | 73 | 3.00 | $211,015 | $25,222 |
| 2022 | 92 | 330 | 74 | 2.68 | $242,805 | $28,471 |
| 2021 | 94 | 282 | 71 | 2.62 | $218,187 | $29,649 |
| 2020 | 94 | 249 | 69 | 2.37 | $135,111 | $17,830 |
| 2019 | 90 | 153 | 69 | 2.74 | $19,602 | $11,382 |
| 2018 | 104 | 202 | 70 | 2.96 | $23,856 | $14,548 |
| 2017 | 105 | 182 | 71 | 3.15 | $38,918 | $13,389 |
| 2016 | 60 | 141 | 71 | 3.13 | $35,935 | $11,065 |
| 2015 | 38 | 66 | 68 | 3.24 | $13,566 | $4,182 |
| 2014 | 11 | 16 | 64 | 2.65 | $2,178 | $624 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 60 | $17,850 | $109 |
| New patient visit (60+ min) | 21 | $2,839 | $135 |
| Return visit (30+ min) | 14 | $1,438 | $68 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 32 | $1,430 | $24 |
2022: 4 services
| Long return visit (40+ min) | 62 | $19,270 | $106 |
| New patient visit (60+ min) | 34 | $4,616 | $136 |
| Return visit (30+ min) | 19 | $1,928 | $69 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 37 | $1,706 | $24 |
2021: 4 services
| Long return visit (40+ min) | 65 | $20,288 | $121 |
| New patient visit (60+ min) | 27 | $4,311 | $160 |
| Return visit (30+ min) | 24 | $2,541 | $75 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 22 | $714 | $25 |
2020: 3 services
| Long return visit (40+ min) | 49 | $8,693 | $91 |
| Return visit (30+ min) | 44 | $4,751 | $62 |
| Short return visit (20+ min) | 21 | $995 | $41 |
2019: 3 services
| Long return visit (40+ min) | 52 | $6,218 | $81 |
| Return visit (30+ min) | 27 | $2,196 | $56 |
| New patient visit (45+ min) | 18 | $1,685 | $94 |
2018: 2 services
| Long return visit (40+ min) | 60 | $7,913 | $82 |
| Return visit (30+ min) | 42 | $4,436 | $58 |
2017: 3 services
| Long return visit (40+ min) | 59 | $7,967 | $83 |
| Return visit (30+ min) | 39 | $2,774 | $55 |
| Short return visit (20+ min) | 12 | $543 | $39 |
2016: 2 services
| Long return visit (40+ min) | 46 | $8,181 | $83 |
| Return visit (30+ min) | 18 | $1,429 | $57 |
2015: 2 services
| Long return visit (40+ min) | 14 | $2,116 | $85 |
| Short return visit (20+ min) | 18 | $811 | $37 |
Medicaid work
$356 in 2021
Medicaid paid $356 for 12 billed services this clinician did in 2021, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 12 | $356 |
| 2021 | 12 | 1 | 12 | $356 |
Drugs they prescribed that Part D paid
$27,517
Pharmacies billed $27,517 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 46% of their Part D prescriptions (168 of 366) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 40% of their opioid prescriptions.
343 generic and 23 brand-name prescriptions · $27,517 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycontin | 14 | $11,226 | $802 |
| Morphine Sulfate Er | 45 | $1,597 | $35 |
| Hydrocodone-Acetaminophen | 24 | $1,540 | $64 |
| Oxycodone | 43 | $997 | $23 |
| Oxycodone-Acetaminophen | 15 | $417 | $28 |
See all 11 drugs
| Oxycontin | 14 | $11,226 | $802 |
| Morphine Sulfate Er | 45 | $1,597 | $35 |
| Hydrocodone-Acetaminophen | 24 | $1,540 | $64 |
| Oxycodone | 43 | $997 | $23 |
| Oxycodone-Acetaminophen | 15 | $417 | $28 |
| Gabapentin | 32 | $375 | $12 |
| Mirtazapine | 12 | $367 | $31 |
| Ondansetron Odt | 12 | $350 | $29 |
| Duloxetine | 30 | $154 | $5 |
| Diclofenac | 16 | $149 | $9 |
| Naproxen | 15 | $114 | $8 |
Year by year
| 2024 | 366 | 58 | 46% (168) | 6% | $27,517 |
| 2023 | 536 | 79 | 42% (224) | 4% | $28,592 |
| 2022 | 529 | 75 | 38% (203) | None | $26,559 |
| 2021 | 445 | 71 | 37% (165) | 9% | $16,039 |
| 2020 | 514 | 80 | 40% (206) | None | $18,969 |
| 2019 | 533 | 87 | 44% (236) | 11% | $35,997 |
| 2018 | 511 | 86 | 53% (273) | 15% | $42,967 |
| 2017 | 438 | 88 | 50% (217) | 16% | $38,399 |
| 2016 | 343 | 68 | 53% (180) | None | $33,698 |
| 2015 | 275 | 63 | 46% (127) | 20% | $38,763 |
| 2014 | 143 | 33 | 79% (113) | 36% | $17,891 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Oxycontin | 11 | $10,455 | $950 |
| Morphine Sulfate Er | 56 | $2,064 | $37 |
| Hydrocodone-Acetaminophen | 43 | $1,674 | $39 |
| Lidocaine | 22 | $1,472 | $67 |
| Oxycodone | 53 | $1,344 | $25 |
| Duloxetine | 33 | $836 | $25 |
| Fentanyl | 12 | $803 | $67 |
| Mirtazapine | 26 | $764 | $29 |
| Gabapentin | 35 | $633 | $18 |
| Diclofenac | 27 | $547 | $20 |
| Oxycodone-Acetaminophen | 14 | $371 | $27 |
| Ondansetron Odt | 17 | $224 | $13 |
| Hydroxyzine | 14 | $139 | $10 |
| Methadone | 14 | $123 | $9 |
2022: 13 drugs
| Fentanyl | 22 | $2,736 | $124 |
| Lidocaine | 22 | $2,582 | $117 |
| Duloxetine | 26 | $2,180 | $84 |
| Oxycodone | 58 | $1,836 | $32 |
| Gabapentin | 60 | $1,699 | $28 |
| Morphine Sulfate Er | 40 | $1,043 | $26 |
| Mirtazapine | 28 | $971 | $35 |
| Oxycodone-Acetaminophen | 21 | $644 | $31 |
| Olanzapine | 12 | $633 | $53 |
| Hydrocodone-Acetaminophen | 17 | $546 | $32 |
| Pregabalin | 13 | $371 | $29 |
| Morphine Sulfate | 14 | $367 | $26 |
| Lorazepam | 17 | $99 | $6 |
2021: 15 drugs
| Oxycodone | 45 | $1,815 | $40 |
| Fentanyl | 18 | $1,622 | $90 |
| Morphine Sulfate Er | 35 | $1,301 | $37 |
| Gabapentin | 39 | $857 | $22 |
| Mirtazapine | 31 | $515 | $17 |
| Diclofenac | 13 | $503 | $39 |
| Pregabalin | 14 | $451 | $32 |
| Tramadol | 16 | $435 | $27 |
| Oxycodone-Acetaminophen | 12 | $418 | $35 |
| Duloxetine | 11 | $318 | $29 |
| Methylphenidate | 18 | $311 | $17 |
| Morphine Sulfate | 19 | $280 | $15 |
| Venlafaxine Hcl Er | 17 | $237 | $14 |
| Baclofen | 14 | $225 | $16 |
| Lorazepam | 16 | $123 | $8 |
2020: 17 drugs
| Oxycodone | 49 | $1,829 | $37 |
| Mirtazapine | 42 | $1,469 | $35 |
| Pregabalin | 23 | $1,304 | $57 |
| Fentanyl | 17 | $1,190 | $70 |
| Lidocaine | 11 | $953 | $87 |
| Morphine Sulfate Er | 34 | $879 | $26 |
| Hydromorphone | 34 | $778 | $23 |
| Gabapentin | 26 | $527 | $20 |
| Hydroxyzine | 19 | $488 | $26 |
| Duloxetine | 15 | $446 | $30 |
| Olanzapine | 15 | $443 | $30 |
| Methadone | 23 | $427 | $19 |
| Methylphenidate | 11 | $303 | $28 |
| Prochlorperazine Maleate | 14 | $245 | $17 |
| Tramadol | 19 | $154 | $8 |
| Paroxetine | 12 | $122 | $10 |
| Lorazepam | 18 | $108 | $6 |
2019: 20 drugs
| Oxycontin | 20 | $14,310 | $716 |
| Lyrica | 14 | $5,856 | $418 |
| Morphine Sulfate Er | 45 | $2,036 | $45 |
| Gabapentin | 49 | $1,661 | $34 |
| Oxycodone | 58 | $1,471 | $25 |
| Fentanyl | 12 | $645 | $54 |
| Duloxetine | 11 | $607 | $55 |
| Hydroxyzine | 27 | $602 | $22 |
| Hydrocodone-Acetaminophen | 17 | $523 | $31 |
| Methadone | 31 | $508 | $16 |
| Hydromorphone | 21 | $503 | $24 |
| Morphine Sulfate | 14 | $474 | $34 |
| Olanzapine | 22 | $471 | $21 |
| Mirtazapine | 13 | $442 | $34 |
| Paroxetine | 23 | $204 | $9 |
| Tramadol | 14 | $186 | $13 |
| Lorazepam | 19 | $93 | $5 |
| Trazodone | 11 | $93 | $8 |
| Escitalopram | 11 | $91 | $8 |
| Omeprazole | 11 | $73 | $7 |
2018: 14 drugs
| Oxycontin | 21 | $13,696 | $652 |
| Lyrica | 23 | $10,104 | $439 |
| Oxycodone | 76 | $2,268 | $30 |
| Gabapentin | 45 | $2,112 | $47 |
| Morphine Sulfate Er | 53 | $2,049 | $39 |
| Fentanyl | 22 | $1,466 | $67 |
| Mirtazapine | 29 | $1,066 | $37 |
| Hydrocodone-Acetaminophen | 22 | $540 | $25 |
| Methadone | 36 | $451 | $13 |
| Methylphenidate | 12 | $431 | $36 |
| Hydromorphone | 19 | $344 | $18 |
| Paroxetine | 15 | $130 | $9 |
| Lorazepam | 13 | $65 | $5 |
| Trazodone | 11 | $61 | $6 |
2017: 11 drugs
| Lyrica | 21 | $11,776 | $561 |
| Oxycontin | 17 | $9,297 | $547 |
| Fentanyl | 15 | $2,336 | $156 |
| Morphine Sulfate Er | 40 | $1,742 | $44 |
| Oxycodone | 55 | $1,650 | $30 |
| Gabapentin | 27 | $1,462 | $54 |
| Mirtazapine | 24 | $893 | $37 |
| Methadone | 35 | $517 | $15 |
| Hydromorphone | 26 | $409 | $16 |
| Methylphenidate | 15 | $408 | $27 |
| Nortriptyline | 12 | $209 | $17 |
2016: 11 drugs
| Lyrica | 18 | $9,062 | $503 |
| Oxycontin | 12 | $4,726 | $394 |
| Fentanyl | 23 | $2,974 | $129 |
| Oxycodone | 43 | $2,767 | $64 |
| Morphine Sulfate Er | 34 | $1,768 | $52 |
| Hydromorphone | 17 | $758 | $45 |
| Duloxetine | 13 | $750 | $58 |
| Methadone | 31 | $510 | $16 |
| Methylphenidate | 14 | $447 | $32 |
| Morphine Sulfate | 14 | $421 | $30 |
| Gabapentin | 17 | $310 | $18 |
2015: 8 drugs
| Morphine Sulfate Er | 22 | $4,817 | $219 |
| Lidocaine | 11 | $3,539 | $322 |
| Fentanyl | 17 | $1,534 | $90 |
| Oxycodone | 23 | $1,053 | $46 |
| Hydromorphone | 20 | $1,006 | $50 |
| Gabapentin | 15 | $679 | $45 |
| Methadone | 22 | $233 | $11 |
| Dexamethasone | 11 | $113 | $10 |
2014: 6 drugs
| Oxycontin | 17 | $5,968 | $351 |
| Lyrica | 14 | $5,213 | $372 |
| Morphine Sulfate Er | 17 | $2,688 | $158 |
| Fentanyl | 18 | $1,672 | $93 |
| Oxycodone | 27 | $788 | $29 |
| Methadone | 13 | $89 | $7 |
Money from drug and device companies
$132 in 2023
A payment is not proof that care is biased.
| Abbott Laboratories | Perclose Proglide | $132 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2023-10-09 | Perclose Proglide | $132 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093000341
- Licence
- CA 18044California C18044: Deceased
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-06-15
- NPI last updated
- 2025-12-30
- NPI record certified
- 2025-12-30
This is when the NPI record was last certified, not a medical board exam.